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Abstract
Background: DNA methylation may mediate effects of air pollution on cardiovascular disease. The association
between long-term air pollution exposure and DNA methylation in monocytes, which are central to atherosclerosis,
has not been studied. We investigated the association between long-term ambient air pollution exposure and DNA
methylation (candidate sites and global) in monocytes of adults (aged ≥55).
Methods: One-year average ambient fine particulate matter (PM2.5) and oxides of nitrogen (NOX) concentrations
were predicted at participants’ (n = 1,207) addresses using spatiotemporal models. We assessed DNA methylation
in circulating monocytes at 1) 2,713 CpG sites associated with mRNA expression of nearby genes and 2) probes
mapping to Alu and LINE-1 repetitive elements (surrogates for global DNA methylation) using Illumina’s Infinium
HumanMethylation450 BeadChip. We used linear regression models adjusted for demographics, smoking, physical
activity, socioeconomic status, methyl-nutrients, and technical variables. For significant air pollution-associated
methylation sites, we also assessed the association between expression of gene transcripts previously associated
with these CpG sites and air pollution.
Results: At a false discovery rate of 0.05, five candidate CpGs (cg20455854, cg07855639, cg07598385, cg17360854,
and cg23599683) had methylation significantly associated with PM2.5 and none were associated with NOX.
Cg20455854 had the smallest p-value for the association with PM2.5 (p = 2.77 × 10
−5). mRNA expression profiles
of genes near three of the PM2.5-associated CpGs (ANKHD1, LGALS2, and ANKRD11) were also significantly
associated with PM2.5 exposure. Alu and LINE-1 methylation were not associated with long-term air pollution
exposure.
Conclusions: We observed novel associations between long-term ambient air pollution exposure and site-
specific DNA methylation, but not global DNA methylation, in purified monocytes of a multi-ethnic adult
population. Epigenetic markers may provide insights into mechanisms underlying environmental factors in
complex diseases like atherosclerosis.
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Background
Ambient air pollution contributed to over 3.2 million
premature deaths and over 76 million years of healthy
life lost globally in 2010 and ranked in the top ten lead-
ing risk factors for global mortality and disease [1].
Exposure to fine particulate matter (PM2.5) has been
associated with a variety of conditions including cardio-
pulmonary disease, diabetes, premature birth, low birth-
weight, cancer, and cognitive changes [2].
Many prior studies focused on the effect of air pollu-
tion exposure on the risk of cardiovascular mortality and
morbidity. Landmark studies including the Harvard Six
Cities and the American Cancer Society studies demon-
strated associations between PM2.5 exposure and all-
cause and cardiovascular mortality in the United States
[3–8]. In addition to mortality, air pollution has also
been associated with ischemic heart disease, stroke, and
progression of atherosclerosis [3, 6, 9–12]. Associations
between air pollution and cardiovascular disease have
also been identified in other countries, including Europe
and China. Long-term exposure to particulate matter
was associated with acute coronary events in 11 Euro-
pean cohorts as part of the ESCAPE Project [13], and
particulate matter and nitrogen dioxide were associated
with increased risk of cardiovascular and cerebrovascular
disease [14, 15]. In a recent review and meta-analysis,
a 10 μg/m3 higher PM2.5 exposure was associated
with a 6% (95% confidence interval [CI]: 4%, 8%)
higher risk for all-cause and 11% (95% CI: 5%, 16%)
higher risk for cardiovascular mortality [16]. Although
much uncertainty exists regarding underlying bio-
logical mechanisms for this association, DNA methy-
lation has been postulated to mediate the effects of
air pollution on cardiovascular disease (CVD) [17].
DNA methylation is a chemical modification of DNA
that involves the addition of a methyl group to cytosine
and predominantly occurs at cytosine-guanine dinucleo-
tide (CpG) sites [18]. DNA methylation in CpG-rich
promoters tends to repress transcription whereas the
effect is context-dependent in other genomic regions.
Previous studies show that DNA methylation patterns
are associated with atherosclerosis [19], ischemic heart
disease [20], and blood pressure while others have sug-
gested DNA methylation as a biomarker for cardiovascu-
lar disease [21]. Moreover, exposure to air pollutants
such as black carbon, particulate matter, benzene, and
SO4 led to a genome-wide reduction in DNA methyla-
tion, or global hypomethylation, and were associated
with methylation levels of candidate genes [22–26].
Results from past studies, however, are difficult to in-
terpret due to several limitations. First, they were limited
by the use of peripheral blood leukocytes, which are
composed of a mixture of cells that have unique DNA
methylation profiles. Since DNA methylation is cell-
specific, it is more relevant to study purified samples of
a single cell type such as monocytes. Monocytes play an
important role in atherogenesis by promoting chronic
inflammation and differentiating into macrophages that
accumulate in plaques [27]. In addition, most prior stud-
ies did not measure gene expression to investigate the
potential biological relevance of methylation differences.
Some studies were further limited by potential exposure
misclassification and measurement error in air pollution
exposures.
We evaluated the association between long-term ex-
posure to ambient air pollution and global and candidate
CpG site DNA methylation in circulating monocytes of
1,207 participants from the Multi-Ethnic Study of
Atherosclerosis (MESA). Candidate CpG sites were
those with methylation previously associated with
expression of nearby genes in the MESA cohort. For
significant air pollution-associated methylation sites, we
also assessed the association between expression of
genes previously associated with the methylation sites
and air pollution. MESA uniquely couples methylomic




MESA enrolled 6,814 participants aged 45–84 free of
CVD at baseline from July 2000 to July 2002 at six field
centers (Baltimore, MD; Chicago, Illinois; Los Angeles,
CA; New York, NY; St. Paul, MN, and Winston-Salem,
NC) with ongoing follow-up [28]. The MESA cohort is a
diverse, population-based sample of 38% white, 28%
black, 22% Hispanic, and 12% Asian participants, of
whom half are women. Study participants underwent ex-
tensive physical exams to determine subclinical CVD
and questionnaires to obtain information on sociodemo-
graphic, lifestyle, and psychosocial factors. MESA Air
began in 2004 and builds on the original MESA study by
adding new participants, outcome measurements, and
air pollution exposure assessments of ambient fine par-
ticulate matter (PM2.5), oxides of nitrogen (NOX), and
black carbon [29]. The MESA Epigenomics and Tran-
scriptomics Study obtained genome-wide methylomic
and transcriptomic profiles of CD14+ purified mono-
cytes from 1,264 randomly selected MESA participants
from four MESA field centers (Baltimore, MD; New
York, NY; St. Paul, MN; and Winston-Salem, NC) at the
5th examination (April 2010-February 2012) [30]. The
study protocol was approved by the Institutional Review
Boards at Johns Hopkins Medical Institutions, University
of Minnesota, Columbia University Medical Center,
Wake Forest University Health Sciences, and University
of Washington. All participants signed informed
consent.
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This study was restricted to participants who had
available methylomic, transcriptomic, and air pollution
data (n = 1,207). Since DNA methylation and gene ex-
pression data were not available for participants from
the Los Angeles and Chicago MESA sites, there were
no Asian participants in our analytic sample. Those
included in the study were generally representative of
all participants from the 5th examination at the four
MESA field centers represented except for having
fewer black participants, more Hispanic participants,
and fewer participants from Winston-Salem, NC (see
Additional file 1: Table S1).
Air pollution assessment
PM2.5 and NOX predictions are available through MESA
Air as likelihood-based 2-week averages for all partici-
pants from 1999 to 2012. The air pollution prediction
method has been described previously [31, 32]. Sources
of monitoring data included the U.S. Environmental
Protection Agency-operated Air Quality System moni-
tors, including data from the Interagency Monitoring of
Protected Visual Environments (IMPROVE) network,
and cohort-specific monitoring. Additional data from
the New York City Community Air Survey (NYCCAS)
were used in New York City [32, 33]. In each study
region, spatiotemporal models that accommodated
unbalanced monitoring data were developed to predict
ambient air pollution concentrations. The prediction
model included monitoring data and over 300 geo-
graphic variables, such as distance to nearest road,
population density, land use, and dispersion model out-
puts [31, 32]. Partial least squares was used to reduce
the dimensionality of geographic covariates for inclusion
in the models. Spatial smoothing was used to borrow
strength between spatially close observations [32]. This
modeling technique used the combined data to
characterize seasonal and shorter-term time trends, key
sources of spatial variability within the study communi-
ties, and underlying spatial and spatiotemporal correl-
ation. For the present analyses, individual-level outdoor
residential concentrations of PM2.5 and NOX were aver-
aged over the 12 months prior to blood draw.
DNA methylation and gene expression quantification
Blood was drawn at the 5th examination (April 2010–
February 2012). Monocytes were purified on-site by
trained technicians following standardized protocols
with extensive quality control measures using anti-
CD14-coated magnetic beads and AutoMACs automated
magnetic separation unit (Miltenyi Biotec, Bergisch
Gladbach, Germany) [30]. DNA and RNA were ex-
tracted simultaneously from purified monocytes using
AllPrep DNA/RNA Mini Kit (Qiagen, Inc., Hilden,
Germany).
Genome-wide methylation profiles of over 485,000
CpG sites were characterized in purified monocytes
using the Infinium HumanMethylation450 BeadChip
(450k; Illumina, Inc. CA, USA). Bisulfite conversion of
DNA fragments was performed with the EZ-96 DNA
Methylation Kit (Zymo Research, Orange, CA, USA).
Bead-level methylation data were summarized using the
Illumina GenomeStudio software, and then raw methyla-
tion calls were normalized and converted to M-values
(log ratio of methylated to unmethylated intensities).
The M-value was used in statistical analyses due to bet-
ter statistical performance in differential methylation
analyses [34]. The Illumina HumanHT-12 v4 Expression
BeadChip and Ilumina Bead Array Reader were used to
obtain genome-wide expression profiles of over 48,000
transcripts (Illumina, Inc. CA, USA) [30]. A random
sampling technique was used to assign samples, includ-
ing control samples, to chips and positions to mitigate
batch effects for both arrays. Data pre-processing using
Bioconductor [35] in R [36] and quality control methods
were previously described [30], and more details can be
found in the Additional file 1. All allosome CpGs were
removed prior to analysis.
To reduce dimensions of our genome-wide methyla-
tion data, we focused on CpG sites more likely to be
functionally relevant. Previous work in this cohort iden-
tified 11,203 methylation sites that were associated with
the cis-expression of 3,093 gene transcripts in a sample
of 1,264 randomly selected MESA participants [30].
There were 2,713 unique CpG sites among the most
significant CpG sites associated with each of the 3,093
transcripts. We tested the association of these 2,713
expression-associated methylation sites (eMS) with
PM2.5 and NOX. In our study, eMS were annotated
with respect to the gene with expression most signifi-
cantly associated to the eMS. Additional nearest gene
annotation for the top eMS can be found in the
Additional file 1: Tables S2 and S3.
Alu and long interspersed nuclear elements (LINE)-1
repetitive element DNA methylation were used as surro-
gates for global DNA methylation. By intersecting probe
locations from the Infinium 450k array with RepeatMas-
ker [37], we identified 12,456 and 9,507 probes for Alu
and LINE-1 repetitive elements, respectively, that passed
quality control exclusion. Median Alu and LINE-1 DNA
methylation were calculated for each participant for use
in regression analyses.
Statistical analysis
The associations between air pollution (PM2.5 or NOX)
and methylation M-values at candidate CpGs were
assessed with least squares regression and robust empir-
ical Bayes moderated t-statistics using the limma pack-
age from Bioconductor [38]. To account for multiple
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testing of the 2,713 eMS, we controlled the false discovery
rate (FDR) at 0.05 using the Benjamini and Hochberg
method [39]. For eMS that were significantly associated
with PM2.5 or NOX, we also tested the association between
the transcript paired to that eMS and PM2.5 or NOX using
linear models with least squares regression and robust
empirical Bayes moderated t-statistics using limma. The
associations between air pollution and median Alu and
median LINE-1 methylation were examined using linear
regression with robust standard errors.
In all analyses, we adjusted for age, sex, race/ethnicity
(black, Hispanic, white), household income, education,
neighborhood socioeconomic status, smoking (smoking
status and pack-years), secondhand smoke, body mass
index, recent infection, methyl nutrient intake (continuous
folate, vitamin B12, vitamin B6, methionine, zinc), physical
activity, study site, microarray chip, and chip position
(DNA methylation analysis only). We also adjusted
for residual sample contamination by non-monocytes
by adjusting for enrichment scores for neutrophils, B
cells, T cells, and natural killer cells.
No covariate had more than 4% missing data. Multi-
variate imputation using chained equations was used to
impute missing values in Stata 13 [40]. Since the propor-
tion of missing data was low, only one iteration was used
in association analyses.
Sensitivity analyses were conducted to investigate
whether the association between exposure to PM2.5 and
NOX and Alu and LINE-1 methylation would be sen-
sitive to a shorter averaging period of two weeks for
the MESA Air likelihood-based air pollution predic-
tions. In addition to including all covariates in the
main study, this analysis also adjusted for temperature,
relative humidity, month of blood draw, and day of week
of blood draw. Additional sensitivity analyses were also
conducted to assess potential effect modification by sex
and race/ethnicity by fitting interaction terms with air
pollution.
Functional annotation analysis
In silico functional prediction of chromatin states in
monocytes was performed using ChromHMM [41] to
predict segmentation among six states, based on his-
tone modifications in monocyte samples from the
BLUEPRINT [42, 43] (H3K27ac, H3K4me1, H3K4me3)
and the Encyclopedia of DNA Elements (ENCODE) [44]
(H3K36me3) projects. Annotation also included DNase
hypersensitive hotspot data in a monocyte sample
(Sample ID RO01746, data generated by the UW
ENCODE group) and transcription factor binding sites
detected in any cell type available from ENCODE
[44]. Data was accessed from the UCSC Genome
Browser [45] and the Gene Expression Omnibus
(https://www.ncbi.nlm.nih.gov/geo/).
Results
The analytic sample consisted of 1,207 participants with
mean age of 69.6 (Table 1). Of these participants, 21.2%
were black, 31.6% were Hispanic, and 47.2% were white.
Roughly half were female, and most were former (50.3%)
or never (40.3%) smokers with average body mass index
of 29.7 kg/m2. Over 65% of participants received educa-
tion beyond high school, and nearly 40% had income
over $50,000. Median Alu and median LINE-1 methyla-
tion were 2.4 and 2.6 M-value units, respectively.
Figure 1 shows plots of site-specific 12-month average
ambient PM2.5 and NOX predictions. The overall average
PM2.5 and NOX predictions were 10.7 μg/m
3 (interquar-
tile range [IQR] = 2.2 μg/m3) and 28.7 ppb (IQR =
31.9 ppb), respectively. PM2.5 and NOX were positively
correlated (correlation coefficient = 0.82). Figure 2 shows
maps of PM2.5 and NOX predictions over the four study
regions, along with participant locations shown in black
dots that are jittered to protect confidentiality.
Figure 3 shows a plot of the –log10(p-values) against
genomic position from linear regression analysis of 2,713
eMS with PM2.5. We found five eMS had methylation
significantly (FDR <0.05) associated with PM2.5 (four
positively and one negatively), and they included
cg20455854 (ANKHD1; ankyrin repeat and KH domain
containing 1), cg07855639 (LGALS2; lectin, galactoside-
binding, soluble, 2), cg07598385 (ANKRD11; ankyrin re-
peat domain 11), cg17360854 (BAZ2B; bromodomain
adjacent to zinc finger domain, 2B), and cg17360854
(PPIE; peptidylprolyl isomerase E). The significant eMS
associated with PM2.5 are shown in Table 2. The eMS
cg20455854 has methylation associated with ANKHD1
expression and is the eMS with the smallest p-value
for the association with PM2.5 (coefficient = 0.139,
95% CI: 0.074, 0.203; per 2.5 μg/m3; p = 2.77 × 10−5).
Cg20455854 is located within a DNase hypersensitivity
site (monocyte data from ENCODE), a transcription
factor binding site (any cell type from UCSC Genome
Browser), and a predicted strong enhancer region (see
Additional file 1: Table S2). NOX exposure was not
significantly associated with methylation of any eMS
(see Additional file 1: Table S3).
Although all candidate CpGs had methylation previ-
ously associated with mRNA expression of a nearby gene
in this cohort, not all of these mRNA expression profiles
associated with PM2.5-associated eMS were significantly
(FDR <0.05) differentially expressed with respect to air
pollution. Three of the five genes with mRNA expression
previously associated with the significant PM2.5-eMS had
mRNA expression also associated with PM2.5. PM2.5
exposure was negatively associated with ANKHD1
(coefficient = −0.048; 95% CI: −0.074, −0.022; per
2.5 μg/m3; p = 3.71 × 10−4), LGASL2 (β = −0.147; 95%
CI: −0.240, −0.053; per 2.5 μg/m3; p = 0.002), and
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ANKRD11 expression (β = −0.075; 95% CI: −0.142,
−0.008; per 2.5 μg/m3; p = 0.028) (Table 2).
Median DNA methylation of Alu was not associated
with PM2.5 (coefficient = −0.003; 95% CI: −0.006, 0.001;
p = 0.155) or NOX (coefficient = 0.001; 95% CI: −0.006,
0.008; p = 0.719) after covariate adjustment (Table 3).
Median DNA methylation of LINE-1 was also not asso-
ciated with PM2.5 (coefficient = −0.003; 95% CI: −0.007,
0.001; p = 0.177) or NOX (coefficient = −0.0004; 95% CI:
−0.009, 0.008; p = 0.927) after covariate adjustment
(Table 3). Results were not sensitive to using a 2-week
averaging period for air pollutants (see Additional file 1:
Table 1 Descriptive characteristics of 1,207 MESA participants











Age (y) 69.6 ± 9.4 69.7 ± 9.7 70.7 ± 9.0 68.5 ± 9.5 71.1 ± 7.0
Race/ethnicity, %
White 570 (47.2) 82 (20.6) 173 (57.5) 267 (58.4) 48 (94.1)
Black 256 (21.2) 125 (31.4) 128 (42.5) 0 (0) 3 (5.9)
Hispanic 381 (31.6) 191 (48.0) 0 (0) 190 (41.6) 0 (0)
Sex, %
Female 623 (51.6) 231 (58.0) 156 (51.8) 208 (45.5) 28 (54.9)
Male 584 (48.4) 167 (42.0) 145 (48.2) 249 (54.5) 23 (45.1)
Smoking status, %a
Never 484 (40.3) 181 (45.8) 120 (40.1) 165 (36.3) 18 (35.3)
Former 604 (50.3) 184 (46.6) 149 (49.8) 244 (53.6) 27 (52.9)
Current 112 (9.3) 30 (7.6) 30 (10.0) 46 (10.1) 6 (11.8)
Secondhand smoke, (hours per week)a 3.7 ± 20.5 2.3 ± (11.1) 5.9 ± 35.3 3.3 ± 12.3 5.5 ± 14.2
Body mass index (kg/m2)a 29.7 ± 5.5 29.3 ± 5.6 30.1 ± 5.7 29.8 ± 5.3 28.5 ± 5.8
Physical activity (MET-min/wk m-su)a 5,696.2 ± 7,205.6 5,364.6 ± 7,139.0 5,978.8 ± 9,405.6 5,942.0 ± 5,770.6 4,405.0 ± 3,314.3
Education, %a
Less than high school 176 (14.6) 94 (23.6) 20 (6.7) 61 (13.3) 1 (2.0)
High school 236 (19.6) 76 (19.1) 59 (19.7) 95 (20.8) 6 (11.8)
Some college but no degree 212 (17.6) 68 (17.1) 59 (19.7) 75 (16.4) 10 (19.6)
Bachelor’s/Associate/Technical 373 (31.0) 99 (24.9) 81 (27.1) 171 (37.4) 22 (43.1)
Advanced degree 208 (17.3) 61 (15.3) 80 (26.8) 55 (12.0) 12 (23.5)
Income, %a
<$25,000 297 (25.5) 131 (33.5) 49 (17.3) 110 (24.9) 7 (14.3)
$25,000–$49,999 371 (31.9) 125 (32.0) 77 (27.2) 150 (34.0) 19 (38.8)
$50,000–$99,999 333 (28.6) 89 (22.8) 104 (36.7) 125 (28.3) 15 (30.6)
$100,000 or more 163 (14.0) 46 (11.8) 53 (18.7) 56 (12.7) 8 (16.3)
Neighborhood socioeconomic status factor scorea −0.41 ± 1.09 −1.06 ± 1.42 −0.27 ± 0.85 0.004 ± 0.62 −0.21 ± 0.91
Recent infection, %a
No 922 (77.2) 293 (73.8) 225 (76.0) 365 (80.8) 39 (78.0)
Yes 273 (22.8) 104 (26.2) 71 (24.0) 87 (19.2) 11 (22.0)
Folate (mcg)a 317.1 ± 169.2 308.5 ± 162.7 301.9 ± 165.0 333.6 ± 175.6 324.1 ± 175.9
Vitamin B12 (mcg)a 3.9 ± 3.8 4.1 ± 5.1 3.6 ± 3.2 4.0 ± 2.8 3.9 ± 2.8
Vitamin B6 (mg)a 1.5 ± 0.8 1.4 ± 0.7 1.5 ± 0.9 1.6 ± 0.8 1.5 ± 0.7
Methionine (g)a 1.4 ± 0.8 1.3 ± 0.8 1.3 ± 0.9 1.5 ± 0.8 1.4 ± 0.8
Zinc (mg)a 8.9 ± 5.2 8.4 ± 4.9 8.3 ± 5.6 9.6 ± 5.2 8.8 ± 4.3
a Contains missing values
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Table S4). We did not identify interactions between air
pollution and sex or race/ethnicity (data not shown).
Discussion
We examined the associations between long-term air
pollution exposure and DNA methylation in mono-
cytes. We found air pollution to be significantly asso-
ciated with site-specific DNA methylation, but not
global DNA methylation. In order to identify poten-
tially functionally relevant genes involved in the
pathogenesis of air pollution-related cardiovascular
disease, we focused on a set of CpG sites that were
previously associated with expression of nearby genes.
In monocytes, we detected five CpGs with methyla-
tion associated with long-term PM2.5 exposure, of
which three were potentially functionally related to

















































Fig. 1 Ambient predictions of PM2.5 and NOX by site, averaged over 12 months prior to blood draw. Site abbreviations: NY, New York;
MD, Maryland; MN, Minnesota; NC, North Carolina. The lower and upper ends of the box represent the 25th and 75th percentiles,
respectively, and the center bar represents the median. The bottom and top whiskers represent 1.5 times the interquartile distance
above and below the 25th and 75th percentiles, respectively, and the circles indicate outliers
Baltimore, MD PM2.5
NO (ppb)XPM (µg/m )2.5
3
Winston-Salem, NC PM2.5
St. Paul, MN PM2.5 New York City, NY PM2.5
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Fig. 2 Maps of estimated PM2.5 and NOX concentrations by MESA Air study site. The maps show smoothed air pollution predictions, which may
reduce the visibility of fine-scale variation in concentrations. Black dots represent participant locations and are jittered to protect
participant confidentiality
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genes with expression also correlated with air pollu-
tion. No site-specific methylation sites were associated
with long-term NOX exposure.
Genes with both regulatory DNA methylation site(s) and
mRNA expression that are associated with air pollution
may be more plausibly involved in the pathogenesis of air
pollution-related disease. In this study, we identified three
such genes: ANKHD1, LGALS2, and ANKRD11. While we
did not formally evaluate whether DNA methylation
mediates the association of air pollution with atheroscler-
otic cardiovascular disease in this report and temporal
relationships are not clear, the identification of these genes
suggests that DNA methylation may potentially link air
pollution inhalation with changes in monocyte gene
expression which could contribute to disease.
ANKHD1 function in monocytes is unknown, but it is
highly expressed in acute leukemia, multiple myeloma,
and prostate cancer and may support proliferation and cell
cycle progression of cancer cells [46–49]. ANKHD1 con-
tains multiple ankyrin repeats [50], which mediate
protein-protein interactions and have been found in pro-
teins involved in various cellular functions including cell-
cell signaling, cytoskeleton integrity, cell cycle control,
transcriptional regulation, and inflammatory response
[51]. The role that ANKHD1 plays in air pollution-related
disease is unclear, but the presence of ankyrin repeats sug-
gests that ANKHD1 may play an important cellular func-
tion. This study is the first to demonstrate an association
between an environmental pollutant and ANKHD1 DNA
methylation and expression. In our study, PM2.5 exposure
correlated with higher methylation of ANKHD1-eMS
cg20455854 and lower mRNA expression of ANKHD1.
The location of cg20455854 within a DNase hypersensitiv-
ity site, transcription factor binding site, and predicted
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Fig. 3 Association between PM2.5 and NOX and 2,713 expression-associated methylation sites. Red line demarcates statistical significance at a false
discovery rate of 5%. Plot for NOX does not have a red line because no sites were statistically significant
Table 2 eMS with PM2.5-associated methylation and association between corresponding transcript gene expression with PM2.5,
ranked by gene expression association with PM2.5
DNA Methylation Gene Expression
Genea Chr CpG β (95% CI) P-value Adjusted
P-value
Illumina Transcript β (95% CI) P-value Adjusted
P-value
PM2.5
ANKHD1 5 cg20455854 0.139 (0.074, 0.203) 2.77 × 10−5 0.034 ILMN_1765091 −0.048 (−0.074, −0.022) 3.71 × 10−4 0.002
LGALS2 22 cg07855639 0.081 (0.043, 0.120) 3.28 × 10−5 0.034 ILMN_1687306 −0.147 (−0.240, −0.053) 0.002 0.005
ANKRD11 16 cg07598385 0.108 (0.056, 0.160) 4.97 × 10−5 0.034 ILMN_2108709 −0.075 (−0.142, −0.008) 0.028 0.046
BAZ2B 2 cg17360854 0.081 (0.042, 0.120) 5.08 × 10−5 0.034 ILMN_1720850 −0.016 (−0.060, 0.027) 0.463 0.578
PPIE 1 cg23599683 −0.057 (−0.085, −0.029) 7.17 × 10−5 0.039 ILMN_1680341 0.004 (−0.020, 0.028) 0.728 0.728
PM2.5, fine particulate matter (per 2.5 μg/m
3); chr chromosome, CI confidence interval
a Gene corresponding to Illumina transcript associated with CpG methylation
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LGALS2 encodes the protein galectin-2, which is part
of the galectin family [52]. Prior studies of LGALS2
function and disease associations have been inconsistent
and sometimes conflicting. Higher galectin-2 levels in
monocytes and macrophages are linked to low arterio-
genic response in coronary artery disease patients [53]
and inflammation [54]. A case–control study in Japan
first reported that the 3279C > T(rs7291467) polymorph-
ism, which reduces galectin expression, was negatively
associated with risk of myocardial infarction [55]. This
single nucleotide polymorphism is located over 380 kb
away from the LGALS2-eMS cg07855639. However, sub-
sequent studies in other Asian and European popula-
tions provided mixed results [56–61]. Studies even
found the TT genotype, which leads to lower levels of
galectin-2, to be associated with more severe coronary
stenosis [62] and higher levels of C-reactive protein [60].
Moreover, addition of galectin-2 to activated T cells
downregulates production of the pro-inflammatory cyto-
kines interferon-γ and tumor necrosis factor-α, while
increasing secretion of interleukin-5 and the anti-
inflammatory cytokine interleukin-10 [63].
Thus while prior studies suggest that galectin-2 may
play a role in cardiovascular disease, potentially by modu-
lating both pro-inflammatory and anti-inflammatory cyto-
kines, the mechanism and direction of association remain
to be determined. In our study, PM2.5 exposure was posi-
tively associated with methylation of the LGALS2-eMS
cg07855639 and negatively associated with LGALS2
mRNA expression in monocytes. While these results sug-
gest that air pollution may potentially affect inflammation,
it is difficult to interpret our results in the context of past
studies given the inconsistency in galectin-2 disease
associations.
ANKRD11 regulates chromatin modification and has
been found to be associated with autism [64] and KBG
syndrome (rare disorder marked by dental, neurobehav-
ioral, craniofacial and skeletal anomalies) [65]. In our
cohort, PM2.5 was positively associated with ANKRD11
methylation and negatively associated with ANKRD11
mRNA expression. Although air pollution is a risk factor
for cardiovascular disease, air pollution has also been
linked to other complex diseases such as autism, where
the common mechanism might be inflammation [66].
BAZ2B and PPIE methylation, but not mRNA expres-
sion, were significantly associated with PM2.5 exposure.
BAZ2B encodes a bromodomain containing chromatin
remodeling protein that epigenetically regulates tran-
scription. Although the function of BAZ2B remains un-
clear, single nucleotide polymorphisms in BAZ2B were
associated with sudden cardiac death [67]. PPIE belongs
to the family of PPIases with proline isomerase activity
that stimulates folding and conformational changes in
proteins and may be linked to leukemia [68], colorectal
cancer [69], and body mass index [70]. Although it is
uncertain how these genes may be related to air
pollution-related disease, this is the first study to report
the novel associations between air pollution and BAZ2B
and PPIE.
While many prior studies focused on the association
between air pollution exposure and global DNA methy-
lation, there is also evidence that air pollution is associ-
ated with DNA methylation of specific genes. Previous
studies identified significant associations between air
pollution exposure and differences in DNA methylation
of several genes including iNOS [71, 72], tissue factor,
intercellular adhesion molecule 1, toll-like receptor 2,
interferon-γ, and interleukin-6 [23]. In addition, an
epigenome-wide study of whole blood using the 450k
array identified 12 CpG sites associated with short- and
mid-term PM2.5 exposures at genome-wide significance
[73]. Of these genes and CpG sites with methylation
previously reported to be associated with air pollution, we
only analyzed methylation of intercellular adhesion
molecule 1 in this study, and it was not associated with
long-term PM2.5 or NOX exposure. The other genes were
not represented among our list of candidate methylation
sites, so we did not analyze the association between their
DNA methylation and air pollution exposure.
We were unable to replicate prior observational stud-
ies that found significant associations between air pollu-
tion exposure and global DNA methylation using Alu
and LINE-1 methylation as surrogates [22, 26, 74].
Short-term controlled human experiments (blood col-
lected 1–30 h post-exposure) showed that exposure to
air pollutants changed DNA methylation levels of Alu
and LINE-1 elements [75, 76]. However, other studies
did not find an association between air pollution and
LINE-1 and/or Alu DNA methylation [22, 71, 74].
Differences in assay method may partially explain our
null associations with global DNA methylation. We
assessed global DNA methylation using probes on the
Illumina 450k array that map to Alu and LINE-1 repeti-
tive elements, unlike most previous studies that used
Table 3 Association between global DNA methylation (Alu and
LINE-1) and one-year average PM2.5 (per 2.5 μg/m3) and NOX
(per 30 ppb)
PM2.5 NOX
β (95% CI)a P-value β (95% CI)a P-value
Alu −0.003 (−0.006, 0.001) 0.155 0.001 (−0.006, 0.008) 0.719
LINE-1 −0.003 (−0.007, 0.001) 0.177 −0.0004 (−0.009, 0.008) 0.927
PM2.5, fine particulate matter; NOX oxides of nitrogen, CI confidence interval,
LINE-1 long interspersed element 1
a Models adjusted for age, race/ethnicity, sex, study site, income, education,
neighborhood socioeconomic status factor score, cigarette smoking,
secondhand smoke, body mass index, physical activity, methyl nutrient intake
(folate, vitamin B12, vitamin B6, methionine, zinc), residual cell contamination
by non-monocytes, recent infection, and methylation chip position. Methylation
values were adjusted for methylation chip prior to regression analysis
Chi et al. Environmental Health  (2016) 15:119 Page 8 of 12
pyrosequencing. We also adjusted for a wider array of
potential confounders not available in prior studies.
Furthermore, our study examined DNA methylation in
purified monocytes whereas previous studies used a mix-
ture of blood cells. Monocytes constitute about 5-10% of
peripheral blood leukocytes [77], highlighting the possi-
bility that the association between air pollution and glo-
bal DNA hypomethylation may be specific to other
leukocytes. Moreover, our study population differs from
those of prior studies. Our study included men and
women age 65 and over who reside in six U.S. regions.
Prior studies included a variety of study populations in-
cluding an elderly cohort of men from the Boston area
(mean age 73), [22, 25] healthy male workers from an
electric steel furnace plant in Italy (mean age 44), [26] and
a predominantly male group of workers from the Ma Ta
Phut industrial estate in Thailand (mean age 31) [74].
We considered the possibility that the difference in
air pollution exposure time windows may explain our
non-significant findings. Previous studies found sig-
nificant associations for short- and intermediate-term
air pollution exposure, rather than long-term expo-
sures that are the primary focus of the MESA Air
project. A study of air pollution and percent 5-
methyl-2′-deoxycytidine methylation found the stron-
gest associations above 7 days, with most of the
effects observed for the 5- to 30-day moving average
exposures [78]. However, in our study, the associa-
tions between 2-week average air pollutant concentra-
tions and global DNA methylation were not
significant in sensitivity analyses.
In our study, we only identified CpGs significantly as-
sociated with PM2.5 but not NOX (at FDR of 0.05).
Sources of ambient PM2.5 include energy generation,
combustion of fuel, agricultural and industrial processes,
and road and wind-blown dust [79]. While motor ve-
hicle emissions contribute to ambient PM2.5, these emis-
sions are one of the main anthropogenic sources of
ambient NOX. Thus, differences in sources and compos-
ition of these two pollutants may partially explain why
observed associations of PM2.5 with methylation were
not observed for NOX.
There are limitations to our study. Our analysis was
cross-sectional, and we were unable to make inferences
about the effect of air pollution on changes in DNA
methylation. In addition, our study was comprised of in-
dividuals in the United States, which has relatively low
air pollution concentrations compared to many parts of
the world. Higher concentrations of air pollutants may
trigger alternate disease mechanisms not captured in this
analysis. Additionally, there may be effect modifiers of
the air pollution-DNA methylation association not in-
vestigated in this study. However, in our sensitivity ana-
lyses we did not find evidence of effect modification by
sex or race/ethnicity. Finally, there may be residual con-
founding by factors not included in the analysis.
Our study is distinct in several ways. Our focus on
purified monocytes greatly enhances the interpretability
of our results and our ability to tease out monocyte-
specific differentially methylated signals that are import-
ant in atherosclerosis. Furthermore, the population-
based sampling, younger age, and multiracial nature of
the MESA cohort allows for greater generalizability of
study results. The coupling of DNA methylation and
gene expression data aids the detection of differentially
methylated sites that may be functionally relevant.
Finally, the state-of-art air pollution assessment in
MESA Air provides individual-level exposures that cap-
ture fine-scale spatial variability in air pollution to
greatly reduce measurement error.
Conclusions
Long-term ambient air pollution exposure was associ-
ated with site-specific DNA methylation, but not global
DNA methylation, in purified blood monocytes obtained
from a multi-ethnic adult population. We identified
genes that may be functionally relevant to mediating air
pollution health effects by focusing on expression-
associated methylation sites. We report novel associa-
tions between PM2.5 exposure and DNA methylation
and expression of ANKHD1, LGALS2, and ANKRD11.
Future research in blood monocytes could address
whether air pollution-associated diseases—such as ather-
osclerosis—may be mediated in part by DNA methyla-
tion epigenetic reprogramming.
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